Alkem Laboratories Limited ALKEM

Latest filings

• Management change25 24 Sept, 13:29 · NSE
  Resignation of Director/KMP/SMP
• Management change45 24 Sept, 12:43 · NSE
  Change in Key Managerial Personnel Resignation of Chief Financial Officer
• Routine15 23 Sept, 14:25 · BSE
  Please find attached herewith intimation of Schedule of Analyst / Institutional Investor Meeting.
• Routine15 23 Sept, 14:20 · NSE
  Schedule of meet
• Routine15 22 Sept, 17:26 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• General25 21 Sept, 17:42 · NSE
  Issue of Corporate Guarantee
• General30 16 Sept, 11:49 · BSE
  Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial - onset seizures in adult patients.
• General25 16 Sept, 11:42 · NSE
  Press Release
• Management change38 15 Sept, 21:08 · NSE
  Appointment of Dr. Shubhadeep Sinha as Senior Management Personnel of the company w.e.f. September 15, 2026.
• General30 8 Sept, 15:08 · NSE
  A press release dated September 08, 2026, titled "Press Release Alkem Laboratories Limited launches Renocia Exo , India s first patented Ginsenoside Exosome-based hair growth serum".

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.